搜尋結果
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC· 8 小時前Amgen on Thursday said it will stop developing its experimental weight loss pill and instead ...
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
Bloomberg· 7 小時前Have a confidential tip for our reporters? Amgen Inc.’s shares soared in late trading after its ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 5 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Wegovy Is Available Again After Shortages, FDA Says—But Supplies Are Still Limited
Forbes· 3 日前The 1.7 milligram (mg) dose of Wegovy is listed as available on the FDA’s drug shortage ...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 3 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 23 小時前Net profit rose 28% year-on-year to 25.4 billion Danish kroner ($3.65 billion), versus analyst ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 6 小時前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Novo Boosts Outlook as More Patients Start on Wegovy for Obesity
Bloomberg· 23 小時前Have a confidential tip for our reporters? Novo Nordisk A/S is shipping more introductory doses ...
Eli Lilly Shares Jump After It Signals Increase in Production of Obesity, Diabetes Drugs
The Wall Street Journal· 3 日前Supply constraints for a popular class of diabetes and obesity drugs limited Eli Lilly’s ...
Rio de Janeiro schools try a new recipe to reduce child obesity
South China Morning Post· 4 日前Instead, students are discovering classic Brazilian fruits and vegetables that are often ...